Alliance Wealth Advisors LLC UT Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alliance Wealth Advisors LLC UT raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,426 shares of the healthcare conglomerate’s stock after purchasing an additional 169 shares during the period. UnitedHealth Group comprises about 1.0% of Alliance Wealth Advisors LLC UT’s portfolio, making the stock its 26th largest holding. Alliance Wealth Advisors LLC UT’s holdings in UnitedHealth Group were worth $2,736,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of UNH. Moneta Group Investment Advisors LLC lifted its stake in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at about $5,210,004,000. Osaic Holdings Inc. grew its position in UnitedHealth Group by 776.9% in the 2nd quarter. Osaic Holdings Inc. now owns 3,248,409 shares of the healthcare conglomerate’s stock worth $177,941,000 after purchasing an additional 2,877,983 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after buying an additional 2,540,538 shares during the period. Finally, Bank of Montreal Can acquired a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $1,087,367,000. 85.69% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.35% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. StockNews.com cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. Stephens restated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday. Oppenheimer reiterated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Piper Sandler decreased their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. Finally, Truist Financial restated a “buy” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Thursday, November 30th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $575.79.

Check Out Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Down 0.3 %

NYSE:UNH opened at $516.70 on Monday. The stock’s 50-day moving average is $525.36 and its two-hundred day moving average is $517.84. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The stock has a market cap of $477.91 billion, a PE ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period last year, the company earned $5.34 earnings per share. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.